REGENXBIO (RGNX) IPO Prices In-Line at $22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- US stock futures down as Middle East strikes fuel inflation anxiety
- Oil rises over 3% as US, Iran resumes military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
REGENXBIO (RGNX) IPO Opens Up 38%
September 17, 2015 11:06 AM EDTToday's IPO for REGENXBIO Inc. (NASDAQ: RGNX) opened for trading at $30.26 after pricing 6,300,000 shares of its common stock at a public offering price of $22.00 per share, inline with the expected pricing. The number of shares offered was raised from 5,555,555 shares.
In addition, REGENXBIO granted the underwriters a 30-day option... More
